Esteva FJ - Search Results

1

Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer.

Fuentes-Mattei E, Velazquez-Torres G, Phan L, Zhang F, Chou PC, Shin JH, Choi HH, Chen JS, Zhao R, Chen J, Gully C, Carlock C, Qi Y, Zhang Y, Wu Y, Esteva FJ, Luo Y, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Fraser Symmans W, Lee MH, Yeung SC. Fuentes-Mattei E, et al. Among authors: esteva fj. J Natl Cancer Inst. 2014 Jun 23;106(7):dju158. doi: 10.1093/jnci/dju158. Print 2014 Jul. J Natl Cancer Inst. 2014. PMID: 24957076 Free PMC article.

2

Locally advanced breast cancer.

Esteva FJ, Hortobagyi GN. Esteva FJ, et al. Hematol Oncol Clin North Am. 1999 Apr;13(2):457-72, vii. doi: 10.1016/s0889-8588(05)70065-4. Hematol Oncol Clin North Am. 1999. PMID: 10363140 Review.

3

Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer.

Pusztai L, Esteva FJ, Cristofanilli M, Hung MC, Hortobagyi GN. Pusztai L, et al. Among authors: esteva fj. Cancer Treat Rev. 1999 Oct;25(5):271-7. doi: 10.1053/ctrv.1999.0132. Cancer Treat Rev. 1999. PMID: 10544071 Review.

4

Adjuvant systemic therapy for primary breast cancer.

Esteva FJ, Hortobagyi GN. Esteva FJ, et al. Surg Clin North Am. 1999 Oct;79(5):1075-90. doi: 10.1016/s0039-6109(05)70062-1. Surg Clin North Am. 1999. PMID: 10572552 Review.

5

Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer.

Esteva FJ, Soh LT, Holmes FA, Plunkett W, Meyers CA, Forman AD, Hortobagyi GN. Esteva FJ, et al. Cancer Chemother Pharmacol. 2000;46(5):382-6. doi: 10.1007/s002800000173. Cancer Chemother Pharmacol. 2000. PMID: 11127942

6

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.

Rivera E, Valero V, Syrewicz L, Rahman Z, Esteva FJ, Theriault RL, Rosales MM, Booser D, Murray JL, Bast RC Jr, Hortobagyi GN. Rivera E, et al. Among authors: esteva fj. J Clin Oncol. 2001 Mar 15;19(6):1716-22. doi: 10.1200/JCO.2001.19.6.1716. J Clin Oncol. 2001. PMID: 11251001 Clinical Trial.

7

Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy.

Buchholz TA, Tucker SL, Erwin J, Mathur D, Strom EA, McNeese MD, Hortobagyi GN, Cristofanilli M, Esteva FJ, Newman L, Singletary SE, Buzdar AU, Hunt KK. Buchholz TA, et al. Among authors: esteva fj. J Clin Oncol. 2001 Apr 15;19(8):2240-6. doi: 10.1200/JCO.2001.19.8.2240. J Clin Oncol. 2001. PMID: 11304777

8

Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond.

Esteva FJ, Valero V, Pusztai L, Boehnke-Michaud L, Buzdar AU, Hortobagyi GN. Esteva FJ, et al. Oncologist. 2001;6(2):133-46. doi: 10.1634/theoncologist.6-2-133. Oncologist. 2001. PMID: 11306725 Free article. Review.

9

Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistry.

Esteva FJ, Hortobagyi GN, Sahin AA, Smith TL, Chin DM, Liang SY, Pusztai L, Buzdar AU, Bacus SS. Esteva FJ, et al. Pathol Oncol Res. 2001;7(3):171-7. doi: 10.1007/BF03032345. Pathol Oncol Res. 2001. PMID: 11692142 Free article.

10

Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.

Esmaeli B, Hortobagyi G, Esteva F, Valero V, Ahmadi MA, Booser D, Ibrahim N, Delpassand E, Arbuckle R. Esmaeli B, et al. Ann Oncol. 2002 Feb;13(2):218-21. doi: 10.1093/annonc/mdf036. Ann Oncol. 2002. PMID: 11885997 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page